Breaking News Instant updates and real-time market news.

IOVA

Iovance Biotherapeutics

$12.06

2.09 (20.96%)

11:37
10/12/18
10/12
11:37
10/12/18
11:37

Iovance Biotherapeutics price target raised to $26 from $22 at H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Iovance Biotherapeutics and raised his price target on shares to $26 from $22, following the outcome of the end-of-Phase 2 meeting with the FDA regarding lead candidate LN-144. Pantginis called the interactions with the FDA "successful," and believes that Iovance will "further pursue its discussion with the agency in order to find the best path forward for LN-144 followed by assets across multiple indications." Additionally, the analyst reiterated his belief that Iovance is a compelling takeout candidate, and added that the company's cash resources provide strong leverage in any discussions.

  • 19

    Oct

  • 12

    Oct

IOVA Iovance Biotherapeutics
$12.06

2.09 (20.96%)

09/06/18
RILY
09/06/18
NO CHANGE
Target $24
RILY
Buy
Moffitt data has little read-across to Iovance platform, says B. Riley FBR
Preliminary clinical data from a Moffitt-sponsored trial of tumor infiltrating lymphocyte therapy in lung cancer has little read-across to Iovance Biotherapeutics' TIL platform, B. Riley FBR analyst Madhu Kumar tells investors in a research note. He reiterates a Buy rating on Iovance with a $24 price target. The stock in morning trading is down 13%, or $2.25, to $14.70.
09/13/18
JEFF
09/13/18
NO CHANGE
Target $31
JEFF
Buy
Feedback on Moffitt TIL study appears positive, says Jefferies
Jefferies analyst Biren Amin hosted a call with an oncologist at Moffitt Cancer Center to review the initial data from this first non-small cell lung cancer tumor infiltrating lymphocytes study. The doctor highlighted the large unmet need in NSCLC patients who failed to respond to anti-PD-1 therapy and feels the 100% disease control rate achieved in the first eight refractory patients to nivo is promising, Amin tells investors in a research note. Further, the oncologist believes the limited duration of response could improve in a second NSCLC study incorporating key "biomarkers," the analyst points out. Amin believes Iovance Biotherapeutics could incorporate some of these key learnings into its two Phase I/II NSCLC studies. The analyst keeps a Buy rating on Iovance with a $31 price target.
09/25/18
COWN
09/25/18
NO CHANGE
COWN
Outperform
Iovance Biotherapeutics weakness a buying opportunity, says Cowen
Cowen analyst Boris Peaker said the recent weakness in Iovance is a buying opportunity. The analyst noted the company's results from the Moffitt-run study of TILS in NSCLC were deemed mild and somewhat disappointing. He believes the data has no read-through to the ongoing melanoma trial, making the weakness an attractive entry point. Peaker reiterated his Outperform rating on Iovance shares.
10/12/18
OPCO
10/12/18
NO CHANGE
Target $25
OPCO
Outperform
Iovance Biotherapeutics price target raised to $25 from $22 at Oppenheimer
Oppenheimer analyst Mark Breidenbach reiterated an Outperform rating on Iovance Biotherapeutics and raised his price target to $25 from $22 citing recent positive clinical updates for its tumor infiltrating lymphocyte product for melanoma and the outcome of discussions with the FDA regarding the regulatory pathway forward.

TODAY'S FREE FLY STORIES

UBER

Uber

$0.00

(0.00%)

06:49
10/19/18
10/19
06:49
10/19/18
06:49
Periodicals
Uber diversifies into short-term staffing business ahead of IPO, FT says »

In an effort to be seen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLP

Valero Energy Partners

$39.94

0.5 (1.27%)

, VLO

Valero

$103.31

-0.36 (-0.35%)

06:48
10/19/18
10/19
06:48
10/19/18
06:48
Downgrade
Valero Energy Partners, Valero rating change  »

Valero Energy Partners…

VLP

Valero Energy Partners

$39.94

0.5 (1.27%)

VLO

Valero

$103.31

-0.36 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 25

    Oct

IBKC

Iberiabank

$75.27

-2.65 (-3.40%)

06:48
10/19/18
10/19
06:48
10/19/18
06:48
Hot Stocks
Iberiabank increases quarterly dividend approximately 5% to 41c per share »

The board of Iberiabank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

STN

Stantec

$24.37

-0.2 (-0.81%)

06:48
10/19/18
10/19
06:48
10/19/18
06:48
Hot Stocks
Stantec to sell MWH Constructors »

Stantec has signed an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

06:44
10/19/18
10/19
06:44
10/19/18
06:44
Upgrade
PayPal rating change  »

PayPal upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

TRV

Travelers

$125.08

-1.39 (-1.10%)

06:44
10/19/18
10/19
06:44
10/19/18
06:44
Downgrade
Travelers rating change  »

Travelers downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.51

-0.255 (-2.91%)

06:41
10/19/18
10/19
06:41
10/19/18
06:41
Downgrade
Ford rating change  »

Ford downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

VIVHY

Vivendi

$0.00

(0.00%)

, TI

Telecom Italia

$5.89

-0.05 (-0.84%)

06:41
10/19/18
10/19
06:41
10/19/18
06:41
Periodicals
Vivendi denies wanting four more members on Telecom Italia's board, Reuters says »

Vivendi (VIVHY) CEO…

VIVHY

Vivendi

$0.00

(0.00%)

TI

Telecom Italia

$5.89

-0.05 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$154.95

-4.51 (-2.83%)

06:39
10/19/18
10/19
06:39
10/19/18
06:39
Periodicals
Facebook's election 'war room' ready for midterms, Business Insider says »

As the U.S. is about to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

ROKU

Roku

$56.99

-3.92 (-6.44%)

06:38
10/19/18
10/19
06:38
10/19/18
06:38
Upgrade
Roku rating change  »

Roku upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 13

    Nov

AEO

American Eagle

$20.94

-0.54 (-2.51%)

06:38
10/19/18
10/19
06:38
10/19/18
06:38
Upgrade
American Eagle rating change  »

American Eagle upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$155.22

-2.73 (-1.73%)

06:37
10/19/18
10/19
06:37
10/19/18
06:37
Earnings
Honeywell lowers FY18 adj. EPS view to $7.95-$8.00 from $8.10-$8.20 »

Consensus $8.15. Lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

SYNH

Syneos Health

$45.94

-0.65 (-1.40%)

06:37
10/19/18
10/19
06:37
10/19/18
06:37
Upgrade
Syneos Health rating change  »

Syneos Health upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,771.45

-61.36 (-3.35%)

06:36
10/19/18
10/19
06:36
10/19/18
06:36
Periodicals
Amazon revisits some cities as HQ2 decision looms, WSJ reports »

Amazon executives have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

MUR

Murphy Oil

$34.63

-0.43 (-1.23%)

, PBR

Petrobras

$15.33

-0.73 (-4.55%)

06:35
10/19/18
10/19
06:35
10/19/18
06:35
Upgrade
Murphy Oil, Petrobras rating change  »

Murphy Oil upgraded to…

MUR

Murphy Oil

$34.63

-0.43 (-1.23%)

PBR

Petrobras

$15.33

-0.73 (-4.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

SYF

Synchrony

$29.63

-0.45 (-1.50%)

06:34
10/19/18
10/19
06:34
10/19/18
06:34
Hot Stocks
Synchrony CEO says 'we generated strong results this quarter' »

"We generated strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 30

    Oct

  • 30

    Oct

CFG

Citizens Financial

$34.92

-0.96 (-2.68%)

06:33
10/19/18
10/19
06:33
10/19/18
06:33
Earnings
Citizens Financial reports Q3 EPS 91c, consensus 90c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

MINI

Mobile Mini

$43.37

0.48 (1.12%)

06:33
10/19/18
10/19
06:33
10/19/18
06:33
Hot Stocks
Mobile Mini CEO says the pipeline in North America looks healthy »

Erik Olsson, Mobile…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

MRO

Marathon Oil

$20.55

-0.33 (-1.58%)

06:33
10/19/18
10/19
06:33
10/19/18
06:33
Upgrade
Marathon Oil rating change  »

Marathon Oil upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

HON

Honeywell

$155.22

-2.73 (-1.73%)

06:32
10/19/18
10/19
06:32
10/19/18
06:32
Earnings
Honeywell reports Q3 adj. EPS $2.03, consensus $1.99 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

MINI

Mobile Mini

$43.37

0.48 (1.12%)

06:32
10/19/18
10/19
06:32
10/19/18
06:32
Earnings
Mobile Mini reports Q3 adjusted EPS 42c, consensus 41c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

WTFC

Wintrust Financial

$79.79

-4.06 (-4.84%)

06:31
10/19/18
10/19
06:31
10/19/18
06:31
Upgrade
Wintrust Financial rating change  »

Wintrust Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$35.27

-0.79 (-2.19%)

06:31
10/19/18
10/19
06:31
10/19/18
06:31
Periodicals
Blackstone waves off concerns over Saudi funding, Reuters reports »

Blackstone Group, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REPYY

Repsol

$0.00

(0.00%)

06:31
10/19/18
10/19
06:31
10/19/18
06:31
Downgrade
Repsol rating change  »

Repsol downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYF

Synchrony

$29.63

-0.45 (-1.50%)

06:31
10/19/18
10/19
06:31
10/19/18
06:31
Earnings
Synchrony reports Q3 EPS 91c, consensus 80c »

Return on assets was 2.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 30

    Oct

  • 30

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.